Mechanism of Action
Tachykinin Receptor Activation
Ranatensin activates NK1 receptors with similar potency to substance P. Gq coupling activates phospholipase C, generating IP3 and DAG, which mobilize intracellular calcium and activate PKC. The NK1 activation produces vasodilation, smooth muscle contraction in the gastrointestinal tract, and modulation of pain signaling in the spinal cord.
Structural Pharmacology
The N-terminal pyroglutamic acid (pGlu) of ranatensin confers resistance to aminopeptidase degradation. Structure-activity studies using ranatensin analogs identified the relative contributions of the N-terminus versus the conserved C-terminal sequence to receptor affinity and subtype selectivity.
Research Summary
Tachykinin SAR Studies
PreclinicalRanatensin was an important tool in early structure-activity relationship (SAR) studies of tachykinins. Systematic substitutions of individual residues identified position 7 (Phe) and position 11 (Met-NH2) as critical determinants of NK1 receptor binding. These studies guided the development of selective NK1 antagonists with therapeutic applications.
Comparison with Eledoisin
PreclinicalParallel pharmacological characterization of ranatensin and eledoisin in different tissue preparations showed differing potency ratios, providing early evidence for tachykinin receptor multiplicity. These comparative data helped establish the existence of distinct NK1 and NK2 receptor subtypes.
Calculate your Ranatensin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| NK1 receptor pharmacology | 1-1000 nM | Single | Organ bath / binding |
| Smooth muscle contraction | 10-100 nM | Single | Isolated tissue |
Research tool only. No therapeutic applications.
Interactions
Safety Profile
Ranatensin produces vasodilation and smooth muscle contraction; no therapeutic use. Research use only in in vitro and animal models.
References
- [1]Anastasi A et al. (1968). Structure and pharmacological actions of ranatensin, a peptide isolated from the skin of Rana pipiens. Experientia, 24(8), 771-773.
- [2]Nawa H et al. (1983). Substance P: regional distribution and comparisons with other tachykinins. Biochemical and Biophysical Research Communications, 114(3), 1103-1112.